+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point of Care Diagnostics/Testing Market Size, Share & Trends Analysis Report by Product (Glucose, Blood Gas/Electrolytes, Cancer Marker), By End Use (Clinic, Hospital), And Segment Forecasts, 2019 - 2025

  • ID: 4479669
  • Report
  • 252 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Abaxis, Inc.
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson
  • Nova Biomedical
  • Qiagen N.V.
  • MORE
The global point of care testing market size is expected to reach USD 22.8 billion by 2025, at a CAGR of 3.3%, according to this report. The ability of Point of Care (POC) tests to render rapid and accurate results to promote patient-centered healthcare at bedside settings as well as in the remote areas results in higher penetration of POC devices and solutions.

Adaptation of automated laboratory systems and highly integrated solutions facilitate the diagnostic workflow, which in turn drives adoption of point of care diagnostic/testing products. Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these devices.

Rise in R&D activities among key players to introduce novel POC tests and devices for rapid disease detection and monitoring is expected to fuel industrial progression. Recently, in February 2018, Siemens Healthineers received a Food and Drug Administration (FDA) approval for its Total Carbon Dioxide (TCO2) and Blood Urea Nitrogen (BUN) POC tests, thereby enhancing its market presence.

Moreover, high prevalence of chronic disorders and cancer results in large customer base adopting cost-effective and immediate diagnostic tests, propelling the point of care diagnostics/testing market. This is further supplemented by numerous favorable initiatives to promote the employment of POC tests in diagnosis and screening procedures.

Further key findings from the report suggest:
  • Glucose testing held the maximum revenue share in 2018 due to high prevalence of diabetes and introduction of a wide variety of glucose meters by companies
  • Hb1Ac testing segment is also expected to show similar trends owing to high competition among key players while delivering low-cost Hb1Ac tests
  • Detection and analysis of circulating tumor cells during cancer progression is predicted to drive the cancer marker vertical with the fastest penetration rate in the forthcoming years
  • Clinics is estimated to hold the dominant revenue share of the POC diagnostic industry in 2018, due to the employment of a wide range of POC tests
  • Increasing awareness about decentralized tests among patients has resulted in lucrative growth of home-based POC testing
  • U.S. is anticipated to North America owing to the presence of key participants with undergoing significant number of research endeavors in the country
  • Continuous developments in healthcare sector to introduce novel and accurate diagnostic tests exhibit a potential growth of the market in Asia Pacific
  • Major participants in the point of care diagnostics market include F. Hoffmann-La Roche Ltd.; Danaher Corporation; Abbott Laboratories; bioMérieux SA; Instrumentation Laboratory SpA; Nova Biomedical; Trividia Health, Inc.; QIAGEN; Becton Dickinson & Company; Sekisui Diagnostics LLC; Quidel Corporation; and Siemens Healthcare GmbH
  • Key vendors are undergoing numerous strategic developments such as product development, acquisitions, partnerships, and agreements to gain greater market share. For instance, in May 2017, Becton, Dickinson and Company collaborated with the FIND to develop point of care based biomarker test for bacterial infections.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abaxis, Inc.
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson
  • Nova Biomedical
  • Qiagen N.V.
  • MORE
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.3.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Point of Care Diagnostics/Testing Market Outlook, 2014 - 2025
2.2 Point of Care Diagnostics/Testing Market : Segment Outlook, 2014 - 2025
2.3 Point of Care Diagnostics/Testing Market : Competitive Insights

Chapter 3 Point of Care Diagnostics/Testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping, 2018
3.3 Product positioning analysis
3.4 Price-cost-margin analysis for point-of-care devices
3.5 User Perspective Analysis
3.5.1. Consumer behavior analysis
3.5.2. Market influencer analysis
3.6 List of Key End-users By Region, By Product, By Country
3.7 Technology Overview
3.7.1. Technology timeline
3.8 Regulatory Framework
3.8.1. Reimbursement framework
3.8.2. Standards & compliances
3.9 Point of Care Diagnostics/Testing Market - Market Dynamics
3.9.1 Market driver analysis
3.9.1.1 Introduction of CLIA waived tests
3.9.1.2 Increasing adoption of POC diagnostics
3.9.1.3 Growing demand for home healthcare and the introduction of advance technology enabled products
3.9.1.4 Growing geriatric population base
3.9.1.5 Growing prevalence of target diseases
3.9.2 Market restraint analysis
3.9.2.1 High procedure costs
3.9.2.2 Presence of ambiguous regulatory framework
3.9.3 Market challenges analysis
3.9.3.1 POC devices pose challenges in maintaining the quality standards
3.10 Point of Care Diagnostics/Testing Market Analysis Tools
3.10.1 Industry Analysis - Porter’s
3.11.1.1 Supplier power : Large scale raw material suppliers results in moderate bargaining supplier power
3.11.1.2 Buyer power: High bargaing power of buyer due to increased demand of POC devices
3.11.1.3 Substitution threat: Low substitution threat owing to the lacking replacement for POC procedures
3.11.1.4 New entrants threat: Low new entrant threat owing to large scale investment for POC set up
3.11.1.5 Competitive rivalry: High capitalization due to product launches led to high competitive rivalry
3.10.2 PESTEL analysis
3.10.2.1 Political landscape
3.10.2.2 Environmental landscape
3.10.2.3 Social landscape
3.10.2.4 Technology landscape
3.10.2.5 Legal landscape
3.10.3 Major deals & strategic alliances analysis
3.10.3.1 Joint ventures
3.10.3.2 Mergers & acquisitions
3.10.3.3 Licensing & partnership
3.10.3.4 Technology collaborations
3.10.3.5 Strategic divestments
3.10.4 Market entry strategies
3.10.5 Case studies

Chapter 4 Point of Care Diagnostics/Testing Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 Key customers
4.3.2 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market share/ranking by region
4.4.3 Competitive dashboard analysis
4.4.4 Market differentiators
4.4.5 Synergy analysis: Major deals & strategic alliances
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Funding outlook
4.5.3 Regional network map
4.5.4 Company market position analysis
4.5.5 Supplier Ranking

Chapter 5 Point of Care Diagnostics/Testing Market: Product Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Product Market Share Analysis, 2018 & 2025
5.3 Point of Care Diagnostics/Testing Market: Product Movement Analysis, 2018 & 2025
5.4. Global Point of Care Diagnostics/Testing Market, by Product, 2014 to 2025
5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
5.5.1 Glucose testing
5.5.1.1 Glucose testing market, 2014 - 2025 (USD Million)
5.5.2 Hb1Ac testing
5.5.2.1 Hb1Ac testing market, 2014 - 2025 (USD Million)
5.5.3 Coagulation testing
5.5.3.1 Coagulation testing market, 2014 - 2025 (USD Million)
5.5.4 Fertility testing
5.5.4.1 Fertility testing market, 2014 - 2025 (USD Million)
5.5.5 Cardiac markers
5.5.5.1 Cardiac markers market, 2014 - 2025 (USD Million)
5.5.6 Infectious disease testing
5.5.6.1 Infectious disease testing market, 2014 - 2025 (USD Million)
5.5.6.2 HIV POC testing
5.5.6.2.1 Global HIV POC testing market, 2014 - 2025 (USD Million)
5.5.6.3 Clostridium Difficile POC testing
5.5.6.3.1 Global Clostridium Difficile POC testing market, 2014 - 2025 (USD Million)
5.5.6.4 HBV POC testing
5.5.6.4.1 Global HBV POC testing market, 2014 - 2025 (USD Million)
5.5.6.5 Pneumonia or streptococcus associated infections
5.5.6.5.1 Global pneumonia or streptococcus associated infections market, 2014 - 2025 (USD Million)
5.5.6.6 Respiratory Syncytial Virus (RSV) POC testing
5.5.6.6.1 Global Respiratory Syncytial Virus (RSV) POC testing market, 2014 - 2025 (USD Million)
5.5.6.7 HPV POC testing
5.5.6.7.1 Global HPV POC testing market, 2014 - 2025 (USD Million)
5.5.6.8 Influenza/flu POC testing
5.5.6.8.1 Global influenza/flu POC testing market, 2014 - 2025 (USD Million)
5.5.6.9 HCV POC testing
5.5.6.9.1 Global HCV POC testing market, 2014 - 2025 (USD Million)
5.5.6.10 MRSA POC testing
5.5.6.10.1 Global MRSA POC testing market, 2014 - 2025 (USD Million)
5.5.6.11 TB and drug-resistant TB POC
5.5.6.11.1 Global TB and drug-resistant TB POC testing market, 2014 - 2025 (USD Million)
5.5.6.12 HSV POC testing
5.5.6.12.1 Global HSV POC testing market, 2014 - 2025 (USD Million)
5.5.6.13 Other infectious diseases POC testing
5.5.6.13.1 Global other infectious diseases POC testing market, 2014 - 2025 (USD Million)
5.5.7 Primary care systems
5.5.7.1 Primary care systems market, 2014 - 2025 (USD Million)
5.5.8 Hematology testing
5.5.8.1 Hematology testing market, 2014 - 2025 (USD Million)
5.5.9 Decentralized clinical chemistry
5.5.9.1 Decentralized clinical chemistry market, 2014 - 2025 (USD Million)
5.5.10 Blood gas/electrolytes testing
5.5.10.1 Blood gas/electrolytes testing market, 2014 - 2025 (USD Million)
5.5.11 Ambulatory chemistry
5.5.11.1 Ambulatory chemistry market, 2014 - 2025 (USD Million)
5.5.12 Urinalysis
5.5.12.1 Urinanalysis market, 2014 - 2025 (USD Million)
5.5.13 Drug abuse testing
5.5.13.1 Drug abuse testing market, 2014 - 2025 (USD Million)
5.5.14 Thyroid stimulating hormone
5.5.14.1 Thyroid stimulating hormone testing market, 2014 - 2025 (USD Million)
5.5.15 Feces testing
5.5.15.1 Feces testing market, 2014 - 2025 (USD Million)
5.5.16 Lipid testing
5.5.16.1 Lipid testing market, 2014 - 2025 (USD Million)
5.5.17 Cancer marker testing
5.5.17.1 Cancer marker testing market, 2014 - 2025 (USD Million)
5.6 Point of Care Diagnostics/Testing Product Market, by End Use, 2014 to 2025

Chapter 6 Point of Care Diagnostics/Testing Market: End Use Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. End Use Market Share Analysis, 2018 & 2025
6.3 Point of Care Diagnostics/Testing Market: End Use Movement Analysis, 2018 & 2025
6.4. Global Point of Care Diagnostics/Testing Market, by End Use, 2014 to 2025
6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
6.5.1 Clinics
6.5.1.1 Clinics market, 2014 - 2025 (USD Million)
6.5.1.2 Pharmacy & retail clinics
6.5.1.2.1 Global pharmacy & retail clinics market, 2014 - 2025 (USD Million)
6.5.1.3 Physician office
6.5.1.3.1 Global physician office market, 2014 - 2025 (USD Million)
6.5.1.4 Urgent care clinics
6.5.1.4.1 Global urgent care clinics market, 2014 - 2025 (USD Million)
6.5.1.5 Non-practice clinics
6.5.1.5.1 Global non-practice clinics market, 2014 - 2025 (USD Million)
6.5.2 Hospitals
6.5.2.1 Hospitals market, 2014 - 2025 (USD Million)
6.5.3 Home
6.5.3.1 Home market, 2014 - 2025 (USD Million)
6.5.4 Assisted Living Healthcare Facilities
6.5.4.1 Assisted living healthcare facilities market, 2014 - 2025 (USD Million)
6.5.5 Laboratories
6.5.5.1 Laboratories market, 2014 - 2025 (USD Million)
6.5.6 Others
6.5.6.1 Other end use market, 2014 - 2025 (USD Million)

Chapter 7 Point of Care Diagnostics/Testing Market: Regional Estimates & Trend Analysis, by Product, & End Use
7.1 Point of Care Diagnostics/Testing Market Share by Region, 2018 & 2025
7.2 Regional Market Share and Leading Players, 2018
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa
7.3 North America
7.3.1 North America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
7.3.2 U.S.
7.3.2.1 U.S. point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.3.2.2 U.S. point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.3.3 Canada.
7.3.3.1 Canada point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.3.3.2 Canada point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.4 Europe
7.4.1 Europe point of care diagnostics/testing market, 2014 - 2025 (USD Million)
7.4.2 Germany
7.4.2.1 Germany point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.4.2.2 Germany point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.4.3 France
7.4.3.1 France point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.4.3.2 France point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.4.4 Italy
7.4.4.1 Italy point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.4.4.2 Italy point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.4.5 Spain
7.4.5.1 Spain point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.4.5.2 Spain point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.4.6 U.K.
7.4.6.1 U.K. point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.4.6.2 U.K. point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.4.7 Russia
7.4.7.1 Russia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.4.7.2 Russia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific point of care diagnostics/testing market, 2014 - 2025 (USD Million)
7.5.2 Japan
7.5.2.1 Japan point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.5.2.2 Japan point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.5.3 China
7.5.3.1 China point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.5.3.2 China point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.5.4 India
7.5.4.1 India point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.5.4.2 India point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.5.5 Australia
7.5.5.1 Australia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.5.5.2 Australia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.5.6 Korea
7.5.6.1 Korea point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.5.6.2 Korea point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.5.7 Singapore
7.5.7.1 Singapore point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.5.7.2 Singapore point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.6 Latin America
7.6.1 Latin America point of care diagnostics/testing market, 2014 - 2025 (USD Million)
7.6.2 Brazil
7.6.2.1 Brazil point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.6.2.2 Brazil point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.6.3 Mexico
7.6.3.1 Mexico point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.6.3.2 Mexico point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.6.4 Argentina
7.6.4.1 Argentina point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.6.4.2 Argentina point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.6.5 Chile
7.6.5.1 Chile point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.6.5.2 Chile point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7 Middle East & Africa
7.7.1 Middle East & Africa point of care diagnostics/testing market, 2014 - 2025 (USD Million)
7.7.2 South Africa.
7.7.2.1 South Africa point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.2.2 South Africa point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7.3 Kenya
7.7.3.1 Kenya point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.3.2 Kenya point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7.4 Nigeria
7.7.4.1 Nigeria point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.4.2 Nigeria point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7.5 Saudi Arabia
7.7.5.1 Saudi Arabia point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.5.2 Saudi Arabia point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7.6 Zimbabwe
7.7.6.1 Zimbabwe point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.6.2 Zimbabwe point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7.7 UAE
7.7.7.1 UAE point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.7.2 UAE point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)
7.7.8 Qatar
7.7.8.1 Qatar point of care diagnostics/testing market, by product, 2014 - 2025 (USD Million)
7.7.8.2 Qatar point of care diagnostics/testing market, by end use, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.3 Company Profiles
8.3.1 F. Hoffmann-La Roche Ltd.
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 Abbott Laboratories
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Siemens Healthcare GmBH
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Danaher Corporation
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 bioMerieux SA
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 Abaxis, Inc.
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Becton Dickinson & Company
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
8.3.8 Qiagen N.V.
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 Spectral Diagnostics
8.3.9.1 Company Overview
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 Instrumentation Laboratory SpA
8.3.10.1 Company Overview
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.10.4 Strategic Initiatives
8.3.11 Johnson and Johnson
8.3.11.1 Company Overview
8.3.11.2 Financial Performance
8.3.11.3 Product Benchmarking
8.3.11.4 Strategic Initiatives
8.3.12 Nova Biomedical
8.3.12.1 Company Overview
8.3.12.2 Financial Performance
8.3.12.3 Product Benchmarking
8.3.12.4 Strategic Initiatives
8.3.13 Nipro Diagnostics Inc
8.3.13.1 Company Overview
8.3.13.2 Financial Performance
8.3.13.3 Product Benchmarking
8.3.13.4 Strategic Initiatives
8.3.14 HemoCue AB
8.3.14.1 Company Overview
8.3.14.2 Financial Performance
8.3.14.3 Product Benchmarking
8.3.14.4 Strategic Initiatives
8.3.15 International Technidyne Corporation (ITC)
8.3.15.1 Company Overview
8.3.15.2 Financial Performance
8.3.15.3 Product Benchmarking
8.3.15.4 Strategic Initiatives
8.3.16 Quidel Corporation
8.3.16.1 Company Overview
8.3.16.2 Financial Performance
8.3.16.3 Product Benchmarking
8.3.16.4 Strategic Initiatives
8.3.17 Trinity Biotech PLC
8.3.17.1 Company Overview
8.3.17.2 Financial Performance
8.3.17.3 Product Benchmarking
8.3.17.4 Strategic Initiatives
8.3.18 Sekisui Diagnostics LLC
8.3.18.1 Company Overview
8.3.18.2 Financial Performance
8.3.18.3 Product Benchmarking
8.3.18.4 Strategic Initiatives
8.3.19 OraSure Technologies Inc
8.3.19.1 Company Overview
8.3.19.2 Financial Performance
8.3.19.3 Product Benchmarking
8.3.19.4 Strategic Initiatives
8.4 List of Companies



*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthcare GmBH
  • Danaher Corporation
  • bioMerieux SA
  • Abaxis, Inc.
  • Becton Dickinson & Company
  • Qiagen N.V.
  • Spectral Diagnostics
  • Instrumentation Laboratory SpA
  • Johnson and Johnson
  • Nova Biomedical
  • Nipro Diagnostics Inc
  • HemoCue AB
  • International Technidyne Corporation (ITC)
  • Quidel Corporation
  • Trinity Biotech PLC
  • Sekisui Diagnostics LLC
  • OraSure Technologies Inc
Note: Product cover images may vary from those shown
Adroll
adroll